Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.
Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check52 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference6%
- Check59 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has been updated with new information as of July 10, 2024, while content from February 7, 2024, has been removed.SummaryDifference0.6%
- Check73 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content or details of the webpage.SummaryDifference0.3%
Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.